NautaDutilh recently assisted Swiss pharmaceutical manufacturer Lonza Group AG (LONN:VTX) with its acquisition of Capsugel SA, a Luxembourg holding company, from private equity firm KKR & Co LP for USD 5.5 billion in cash, including the refinancing of approximately USD 2 billion in Capsugel debt.

The transaction was financed with a combination of debt and equity, and the parties signed the acquisition agreement on 15 December 2016.

Capsugel manufactures empty, two-piece hard capsules and finished dosage forms for drug delivery. With approximately 3,600 employees, it serves more than 4,000 corporate customers in over 100 countries and owns and operates 13 manufacturing sites, three of which also house R&D centres of excellence (including one in Bornem, Belgium).

NautaDutilh advised on all Belgian and Luxembourg legal aspects of the deal including due diligence, deal structure, share purchase agreement, etc. Jenner & Block LLP acted as Lonza’s lead counsel.

Our team was led by Elke Janssens and Maxime Colle in Belgium and Greet Wilkenhuysen and Aline Nassoy in Luxembourg.